Cladribine for mastocytosis: benefits and risks
نویسندگان
چکیده
منابع مشابه
Cladribine therapy for systemic mastocytosis.
Patients with systemic mastocytosis (SM) can suffer from disabling symptoms related to mast cell mediator release or mast cell infiltration, requiring mast cell eradication. In the present absence of any curative therapy, a recent case report describing the efficacy of cladribine showed promising results. In a pilot study, the efficacy of cladribine (0.10-0.13 mg/kg in a 2-hour infusion, days 1...
متن کاملNanocosmetics: benefits and risks
Various nanomaterials/nanoparticles (NPs) have been used for the development of cosmetic products - a field so-called nanocosmetic formulations. These advanced materials offer some benefits, while their utilization in the cosmetic formulations may be associated with some risks. The main aim of this editorial is to highlight the benefits and risks of the nanomaterials used in the cosmetic products.
متن کاملClozapine: benefits and risks.
The National Institute of Mental Health and Dr. David Shore are to be thanked and congratulated for the very complete and informative issue of the Schizophrenia Bulletin entitled "Special Report: Schizophrenia 1993." Somehow the dangers of clozapine have been grossly exaggerated. Let us look at the facts. There are now over 60,000 patients being treated with clozapine in the United States. Ther...
متن کاملXenotransplantation: benefits and risks.
545 able organic carbon level, degree of pipe corrosion, and treatment/distribution system characteristics. Chloramine is considerably more effective than chlorine for controlling Legionella in biofilms, presumably because chloramine is more stable and thus less reactive than chlorine, allowing it to penetrate the biofilm more deeply. An important factor in distribution system contamination and...
متن کاملLong-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.
Mastocytosis (M) is a clonal myeloid-disabling disorder for which no curative therapy is currently available. Cladribine (2-chlorodeoxyadenosine [2-CdA]) is a synthetic purine analog cytoreductive treatment, for which efficacy is mostly reported in advanced M. Here we report, with a long-term follow-up period (>10 years) efficacy and safety in 68 adult patients with M (36 [53%] had indolent M a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2015
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood-2015-06-649525